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Abstract
Background: Brain injury results in an increase in the activity of the reactive oxygen species generating NADPH
oxidase (NOX) enzymes. Preliminary studies have shown that NOX2, NOX3, and NOX4 are the most prominently
expressed NOX isotypes in the brain. However, the cellular and temporal expression profile of these isotypes in the
injured and non-injured brain is currently unclear.
Methods: Double immunofluorescence for NOX isotypes and brain cell types was performed at acute (24 hours),
sub-acute (7 days), and chronic (28 days) time points after controlled cortical impact-induced brain injury or
sham-injury in rats.
Results: NOX2, NOX3, and NOX4 isotypes were found to be expressed in neurons, astrocytes, and microglia, and
this expression was dependent on both cellular source and post-injury time. NOX4 was found in all cell types
assessed, while NOX3 was positively identified in neurons only, and NOX2 was identified in microglia and neurons.
NOX2 was the most responsive to injury, increasing primarily in microglia in response to injury. Quantitation of this
isotype showed a significant increase in NOX2 expression at 24 hours, with reduced expression at 7 days and 28
days post-injury, although expression remained above sham levels at later time points. Cellular confirmation using
purified primary or cell line culture demonstrated similar patterns in microglia, astrocytes, and neurons. Further,
inhibition of NOX, and more specifically NOX2, reduced pro-inflammatory activity in microglia, demonstrating that
NOX is not only up-regulated after stimulation, but may also play a significant role in post-injury neuroinflammation.
Conclusions: This study illustrates the expression profiles of NOX isotypes in the brain after injury, and demonstrates
that NOX2, and to a lesser extent, NOX4, may be responsible for the majority of oxidative stress observed acutely
after traumatic brain injury. These data may provide insight into the design of future therapeutic approaches.
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Background
In the United States alone, there are over 1.7 million
cases of traumatic brain injury (TBI) contributing to
a third (30.5%) of all injury-related deaths in the
United States [1]. Secondary tissue damage and cell
death follows the initial mechanical insult, expanding
from the primary injury site and contributing to per-
manent motor, autonomic, and sensory function loss
(for a review, see [2]). Inflammation, including activa-
tion of microglia, astrogliosis, and oxidative stress, play
central roles in this secondary injury [3-6].
Oxidative stress results from an accumulation of
reactive oxygen species (ROS), produced by a cas-
cade of reactions that start with the reduction of
oxygen to yield superoxide (O2
•-). ROS readily inter-
act with a wide range of other small inorganic and
biological molecules, which frequently results in cel-
lular and tissue damage, particularly under acute or
chronic inflammatory conditions [7]. A major source of
ROS in the injured nervous system is the nicotinamide
adenine dinucleotide phosphate (NADPH) oxidase
(NOX) enzyme. All NOX family members are trans-
membrane electron carriers that use cytosolic NADPH
as an electron donor and transport electrons through flavin
adenine dinucleotide (FAD) and membrane-embedded
hemes to reduce oxygen to superoxide. Superoxide largely
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dismutates to hydrogen peroxide (H2O2), catalyzed by
superoxide dismutase or spontaneously at low pH [7,8].
Furthermore, peroxide and superoxide can react to pro-
duce hydroxyl radicals (HO•) in the presence of metal
ions. Additionally, superoxide reacts with nitric oxide
to form the highly reactive intermediate peroxynitrite.
There are seven known isotypes of the catalytic
NOX subunit: NOX1, NOX2, NOX3, NOX4, NOX5,
DUOX1, and DUOX2. Cellular expression of NOX
in the brain, as well as the rest of the body, appears
to be isotype dependent. NOX2 is the primary
phagocytic oxidase [9-14]; NOX1 and 2 have been
shown to be expressed in neurons [10,14,15], smooth
muscle cells [9,16], and microglia [9-14]. Savchenko
et al. demonstrated that expressions of NOX1 and
NOX2 are altered in microglia and neurons after
stimulation in vitro [10]. Studies have also shown
that NOX2 is up-regulated in microglia upon activation
in cases of multiple sclerosis [11], ischemia [14], and
TBI [17]. Moreover, we have demonstrated that NOX2
components are up-regulated in the spinal cord after
injury [18-20]. NOX3 is less studied, but has been
shown primarily in the vestibular system to date [21].
NOX4, which does not require any cytosolic components
and is constitutively active, is expressed highly in the kid-
ney [22] and vascular smooth muscle cells [16], and to a
lesser extent in neurons [23] and astrocytes [24]. Finally,
NOX5 is expressed in fetal tissues and spleen [9], while
DUOX1 and 2 are highly expressed in the thyroid where
they produce H2O2 [7].
Numerous studies have shown evidence of oxida-
tive stress and ROS-mediated damage after TBI, al-
though the source of these ROS is unclear. While
some of the acute ROS production may be a result
of mitochondrial dysfunction [25], NOX is also likely
to play a role. NOX activity has been shown to have
an early peak at 1 hour after controlled cortical im-
pact (CCI) injury in mice, followed by a secondary
peak between 24 and 96 hours post-injury [26,27].
NOX2 specifically, as well as ROS activity, have been
identified in microglia, neurons, and astrocytes, at
48-hours post-CCI injury in mice [17]. In a diffuse
brain injury study, NOX2 expression and activity was ele-
vated in the hippocampus between 48 and 72 hours post-
injury [28].
While most studies have investigated acute NOX
activity, few studies have shown evidence of chronic
NOX activity in the brain and spinal cord after in-
jury and oxidative stress [19,29,30]. Further, to date,
the temporal and cellular expression of NOX iso-
types in the brain and their potential role in oxida-
tive stress after injury have not been clarified. Our
preliminary studies have shown that NOX2, NOX3,
and NOX4 are the principle isotypes expressed in
the central nervous system. Therefore, the aim of
this study was to identify the temporal profile and
cellular localization of the NOX2, NOX3, and NOX4
isotypes in the normal and injured brain. We now
show that there is temporal and cellular differenti-
ation in the localization of NOX isotypes in the brain,
and that NOX-induced ROS production may stem from
different cells at different time points. Further, we show
that inhibition of NOX, both non-specifically and specific-
ally for NOX2, can inhibit microglial pro-inflammatory re-
sponses and reduce microglial-induced cellular toxicity.
Methods
Animal handling and surgical methods
Adult male Sprague Dawley rats (275–325 g) were
used for all experiments. Rats were dual housed and
received food and water ad libitum with a 12:12
hour light cycle. A total of 23 adult male Sprague
Dawley rats were used for this study. All experi-
ments complied fully with the principles set forth in
the “Guide for the Care and Use of Laboratory Ani-
mals” prepared by the Committee on Care and Use
of Laboratory Animals of the Institute of Laboratory
Resources, National Research Council (DHEW pub. No.
(NIH) 85-23, 2985) and were approved by the Uniformed
Services University Institutional Animal Care and Use
Committee.
Moderate CCI injury was performed using the
Leica Impact One (Leica Microsystems, Buffalo
Grove, IL, USA), as previously described with modi-
fication [31]. Briefly, rats were anesthetized with iso-
flurane evaporated in a gas mixture containing 70%
N2O and 30% O2 and administered through a nose
mask (induction at 4% and maintenance at 2%). Ani-
mals were placed into a stereotaxic frame and a 5
mm craniotomy was made using a 5 mm tip diam-
eter microdrill trephine (Fine Science Tools, Foster
City, CA, USA) on the central aspect of the left par-
ietal bone, at stereotaxic coordinates Bregma -3 mm
posterior, -2.5 mm lateral. Moderate-level injury was
induced with a 3 mm flat impactor tip at an impact
velocity of 5 m/s, deformation depth of 2 mm and
dwell time of 200 ms. Sham injured animals under-
went the same experimental procedures, but received
a craniotomy only. Naïve animals underwent no sur-
gery or anesthesia. Body temperature was monitored
and maintained throughout all surgical procedures
using a rectal thermometer and heating pad. Follow-
ing impact or sham-impact, the craniotomy was left un-
sealed and the incision was closed with sutures. Animals
were allowed to recover on heating pads and received
acetaminophen (200 mg/kg) in drinking water for 72
hours post-injury.
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Immunohistochemistry
At 24 hours (n = 4 injured, 2 sham), 7 days (n = 5 injured,
2 sham), and 28 days (n = 4 injured, 2 sham) after surgery
or 1 week after delivery (naïve; n = 4), rats were terminally
anesthetized (sodium pentobarbital solution [Euthasol,
Virbac, Ft. Worth, TX, USA], 0.22 mL/kg, I.P.) and intra-
cardially perfused with 100 mL of 0.9% saline followed by
300 mL of 10% buffered formalin. A 5-mm section of
brain centered at the lesion epicenter (or equivalent
location in sham/naïve tissue) was dissected, post-fixed
in 10% buffered formalin overnight, and cryoprotected
in 30% sucrose for 48 hours.
Standard hematoxylin and eosin staining (H&E) was
performed on serial 20-μm thick coronal sections and
photographed at × 20 using NanoZoomer Digital Path-
ology system (Hamamatsu Photonics, K.K., Japan).
Standard single or double fluorescent or diamino-
benzidine (DAB)-based immunohistochemistry on ser-
ial 20-μm thick coronal sections was performed as
described previously [18]. Antibodies included NOX2/
gp91PHOX (1 μg/mL; Abcam, Cambridge, MA, USA),
NOX3 (18 μg/mL, Santa Cruz Biotechnology, Santa Cruz,
CA, USA), NOX4 (1 μg/mL, Abcam), Iba-1 (1 μg/mL,
Wako, Richmond, VA, USA), NeuN (1:100, Millipore,
Billerica, MA, USA), GFAP (1:1,000, Abcam), and CD11b
(2 μg/mL, Serotec, Oxford, UK) .
Appropriate secondary antibodies linked to AlexaFluor
dyes (Invitrogen, Carlsbad, CA, USA) were incubated with
tissue sections for 1 hour at room temperature. Slides
were coverslipped using mounting media containing DAPI
to counterstain for nuclei (Vector Labs, Burlingame, CA,
USA). For NOX3 immunohistochemistry, the Vector ABC
kit with DAB and/or NovaRed reaction products were uti-
lized due to poor resolution with secondary fluorescence
(Vector Labs).
To ensure accurate and specific staining, negative
controls were used in which the primary antibody was
not applied to sections from injured tissue, and only
staining of cells that were double-labeled with expected
cell markers or had expected labeling patterns (i.e., classic
microglia morphology) was confirmed as positive label-
ing. In addition, western blotting for each NOX isotype
showed a single band, suggesting specificity of the anti-
body (data not shown).
Immunofluorescence was detected using an Olympus
DP72 microscope with Olympus cellSens microscopy
software (Olympus, Center Valley, PA, USA). Scion
Image Analysis (http://rsb.info.nih.gov/nih-image) was
used to assess pixel density of resultant NOX2+ immuno-
labeling using stain intensity as threshold. Measurement
was performed on × 5 images obtained with the Nano-
Zoomer Digital Pathology System in the perilesional re-
gion in a 4.23 mm2 rectangular region of interest centered
on the lesion epicenter. The size of the region of interest
was maintained for all quantification of images. For all
quantitative and qualitative assessments, a minimum
of five images were collected from regular intervals
throughout the 5 mm length of the lesion, to be repre-
sentative of the lesion and peri-lesional region.
Because no marked differences were observed between
sham-injured and naïve animals at any time point, data
from these animals was combined into a single sham/
naïve group for all comparisons and analyses.
In vitro experiments
The BV2 microglial cell line (a gift from Dr. Carol Colton)
was cultured and replated to wells at passage 14 to 19.
The PC12 neuronal cell line (ATCC, Manassas, VA, USA)
was cultured and replated to wells at passage 3 to 5. Pri-
mary cortical astrocytes were obtained from neonatal rat
pups as previously described [32]. Briefly, the whole brain
was dissected from P2 Sprague Dawley rat pups and
homogenized. Mixed glial cultures were then incubated
for 8 to 10 days at 37°C with 5% CO2 in Dulbecco’s modi-
fied Eagle media (Invitrogen) with 10% fetal calf serum
(Hyclone, Logan, UT, USA), 1% L-glutamine (Invitrogen),
1% sodium pyruvate (Invitrogen), and 1% Pen/Strep
(Fisher, Pittsburgh, PA, USA). After the initial incubation,
the cells were shaken for 1 hour at 100 rpm and 37°C to
remove microglia. The flasks were then returned to the
shaker for 3 days (with media changes every morning), at
200 rpm and 37ºC. After shaking, astrocytes were removed
from the flasks by trypsinization and transferred to new
flasks. Primary oligodendrocytes were cultured similarly,
as previously described [33]. Briefly, the whole brain from
neonatal rat pups was isolated and used to generate mixed
glial cultures. At 10 days after culture, flasks were shaken
overnight at 200 rpm. Cells were then plated onto poly-
L-lysine coated plates in DMEM as described above,
containing 30 ng/mL of T3 (Sigma, St. Louis, MO, USA)
to generate mature oligodendrocytes.
Treatments
BV2 cells and astrocytes were treated with lipopolysac-
charide (LPS; 100 ng/mL, Sigma), Phorbol-12-Myristate-
13-Acetate (PMA; 10 to 500 ng/mL in DMSO, Santa Cruz
Biotechnology) or control vehicle media for 24 hours.
NOX inhibitors diphenyleneiodonium (DPI; 100 nM to 10
μM in DMSO, Sigma) or gp91ds-tat peptide (1 to 100 μM,
AnaSpec, Fremont, CA, USA) were applied 1 hour prior
to LPS or PMA. Control for NOX inhibitors included 1%
DMSO in media or scrambled ds-tat (10 μM, AnaSpec).
All drugs were prepared and stored according to the
manufacturer’s guidelines.
Co-culture
PC12 media was replaced with conditioned media from
BV2 cells that were treated with LPS or control media
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for 24 hours. After 24 hours in BV2 media, cells were
fixed with 4% paraformaldehyde and immunostained as
described above.
For oligodendrocyte co-culture, BV2 cells were cul-
tured in 24-well plate Transwell slips for 24 hours
with LPS or vehicle. After 24 hours, Transwells were
transferred to 24-well plates containing oligodendro-
cytes and cultured for an additional 24 hours. Cell
death of oligodendrocytes was measured by lactate de-
hydrogenase release assay following removal of Trans-
wells containing microglia (CytoTox96TM cytotoxicity
assay, Promega, Madison, WI, USA). Measurements
are presented as percentage of maximal lactate dehydro-
genase (LDH) release following treatment of oligoden-
drocytes with lysis solution (following manufacturer’s
instructions).
Immunocytochemistry
BV2, astrocyte and PC12 cells were fixed with 4% parafor-
maldehyde at 24 hours after treatment and immunostained
as described above for NOX isoforms. All immunocyto-
chemical assessments were made from three separate
cultures for each antibody and cell type.
Figure 1 H&E tissue staining showing a steady lesion evolution over time. Injury site (dotted circles) can be observed at 24 hours, 7 days,
and 28 days post-injury. Images are representative from within the 5 mm segment encompassing the lesion site. Bar = 2.5 mm.
Figure 2 Microglia were positive for NOX2 ipsilateral to the injury site. Microglia were labeled with CD11b (green) and immunostained with
an antibody against NOX2 (red) in sham-injured tissue and at 24 hours, 7 days, and 28 days post-injury. Co-labeled cells are indicated with arrows.
NOX2+ cells increased by 24 hours post-injury and increased further by 7 days post-injury, but by 28 days post-injury staining resembled sham.
Bar = 20 μm (A, B, D); 50 μm (C).
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Nitric oxide (NO) assay
Briefly, BV2 microglia were pre-treated for 1 hour with
gp91ds-tat (1 to 100 μM) or DPI (100 nM to 10 μM),
or respective controls prior to stimulation with LPS
(100 ng/mL), and incubated at 37°C and 5% CO2 for 24
hours. NO• production was assayed using the Griess
Reagent Assay kit (Invitrogen), according to the manu-
facturer’s instructions [34]. Colorimetric changes in
96-well plates were assessed using a Chroma Plate
Reader (Midwest Scientific, St. Louis, MO, USA) at
545 nm. Data are presented as percentage of control-
treated values.
Measurement of intracellular ROS
BV2 microglia were pre-treated for 1 hour with gp91ds-tat
(1 to 50 μM) or DPI, or respective controls, and exposed
to PMA or LPS stimulation. Cells were then incubated
at 37°C and 5% CO2 for 24 hours. The cells were incu-
bated with 10 μM 2’,7’-dichlorodihydrofluorescein dia-
cetate (Molecular Probes, Eugene, OR, USA) for 45 min
at 37°C in 5% CO2. Fluorescence was measured using
excitation and emission wavelengths of 490 and 535 nm,
respectively. Data are presented as percentage of control-
treated values.
Statistics
Quantitative data are presented as mean ± standard devi-
ation. Pixel density was obtained in at least five separate
sections by an investigator blinded to treatment group.
Quantitative cell culture data were obtained from three
separate experiments and presented as an average of
those data. Data were analyzed using one-way ANOVA
with Tukey post-test. All statistical tests were performed
using the GraphPad Prism Program, Version 5.0 for
Windows (GraphPad Software, San Diego, CA, USA). A
P value <0.05 was considered statistically significant.
Results
NOX isotypes were evaluated in tissue from sham or naïve
rats or from rats that had received a CCI injury 24 hours,
7 days, or 28 days previously. H&E tissue staining showed
an evolution of the lesion over time (Figure 1). Tissue
showed an initial swelling, followed by slight cavitation
and tissue disorganization, then larger cavitation at 28
days post-injury. All measurements of NOX isotypes
were made in the lesion epicenter and perilesional region
surrounding these sites (Figure 1).
Microglia/macrophages
In uninjured brain, CD11b+ microglia were small and
few in number; many were NOX2+ (Figure 2). By 24 hours
post-injury, CD11b+ cells showed signs of activation, in-
cluding increased cell size and number. At this point,
most, but not all were also NOX2+, resulting in an in-
crease in NOX2+ labeling in comparison to sham/naïve
tissue. By 7 days post-injury, CD11b+ cell number was
elevated and NOX2 staining appeared to be similarly
increased, although, again, not all CD11b+ cells were
also NOX2+, and many NOX2+ cells were not CD11b+.
By 28 days, the number of CD11b+ cells had reduced to
24-hour post-injury levels, and NOX2 staining decreased
to resemble 24-hour levels as well.
Quantitation of NOX2 was performed in tissue from
sham/naïve, 24 hour, 7 day, and 28 day injured rats. A
significant increase in NOX2 was observed at 24 hours
(F3,9 = 4.331, P <0.05; Figure 3). By 7 days, the amount
of NOX2 immunolabeling had reduced. Further reduc-
tion was observed at 28 days, but was still significantly
elevated over sham. CD11b+/NOX3+ cells were difficult
to identify in brain tissue, so the data was inconclusive
(data not shown).
Unlike NOX2, small, sparsely arranged CD11b+
cells from sham/naïve tissue were NOX4- (Figure 4).
By 24 hours post-injury, the number and size of CD11b+
cells was increased, and double staining with NOX4 was
frequently observed. NOX4 staining, like NOX2, also in-
creased by 7 days post-injury, and most of the CD11b+
cells were now NOX4+. By 28 days, both CD11b and
NOX4 staining decreased to resemble 24-hour post-injury
tissue, and demonstrated several CD11b cells that were
not positive for NOX4.
Figure 3 NOX2 expression increases significantly ipsilateral to
the injury site. Immunofluorescence detection for NOX2 was
performed on tissue sections from naïve/sham animals and animals
at 24 hours, 7 days, and 28 days after moderate brain injury. Protein
expression was measured from the midline to the edge of the injury
site by densitometry analysis using stain intensity threshold. NOX2
staining increased by 24 hours post-injury, and was reduced at 7
and 28 days post-injury, although it remained significantly greater
than naïve/sham at 28 days. Points represent individual measurements;
line at mean and SD. *P <0.05 in comparison to naïve/sham.
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In vitro, unstimulated microglia demonstrated NOX2,
NOX3, and NOX4 staining (Figure 5). The intensity of
NOX2 and NOX4 staining increased in microglia stimu-
lated with LPS, while NOX3 staining decreased. The
distribution of NOX2 changed from the entire cell body
in unstimulated microglia to a dense ring surrounding
the nucleus in LPS stimulated microglia.
Neurons
In both uninjured and injured brains, the majority of
NeuN+ cells were NOX2+ (Figure 6). The relative amount
of staining remained unchanged at 24 hours post-injury,
but at 7 days post-injury NeuN+/NOX2+ were no longer
observed, despite sustained presence of NeuN+ cells.
NOX2 staining returned to NeuN+ cells by 28 days
post-injury to the level observed in sham/naïve and
24-hour post-injury tissue.
NeuN+ cells in uninjured tissue were also NOX3+ (data
not shown) and remained so through all post-injury time
points, with no obvious alterations in expression profile.
Like NOX2, NeuN+ cells were found to be NOX4+ in
uninjured tissue, with most, although not all, NeuN+
cells showing NOX4 immunostaining (Figure 7). Brain
tissue remained NOX4+/NeuN+ at 24 hours, with no
marked change in the number of cells showing double
staining. However, like NOX2, NeuN+ cells appeared to
lose NOX4 staining at 7 days post-injury. By 28 days
post-injury, NOX4 staining returned to NeuN+ cells, at
levels similar to that seen in sham/naïve tissue.
PC12 neuronal like cells were cultured in conditioned
control microglial media or in media from microglia
that were treated with LPS to test NOX expression in
these cell types. NOX2 labeling was consistent in both
treatments. However, NOX4 labeling decreased in PC12
cells that were cultured in LPS-treated microglial media
(Figure 8).
Astrocytes
Neither injured nor uninjured brain sections showed
positive labeling for NOX2 or NOX3 in GFAP+ cells in
the brain (data not shown). However, at both 24 hours
and 28 days post-injury, there was co-labeling of GFAP
and NOX4 (Figure 9). Interestingly, no double labeling
of NOX4 and GFAP was observed in sham/naïve tissue
or at 7 days post-injury.
Figure 4 Microglia were NOX4+ ipsilateral to the injury site. Cells labeled with the microglial marker CD11b (green) were not NOX4 (red)
positive in naïve animals. By 24 hours and 7 days post-injury, some cells positive for CD11b were also positive for NOX4 (arrows). By 7 days
post-injury, all CD11b+ cells in the injury site were positive for NOX4. At 28 days, not all of the CD11b+ cells were NOX4+. Bar = 50 μm.
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In vitro, astrocytes were NOX2+ and NOX4+, but NOX3-
(Figure 10). No change in NOX expression was observed
over time, nor with LPS treatment.
In vitro experiments
In order to determine if NOX activity in microglia con-
tributes to the response of microglia following a neu-
roinflammatory challenge, BV2 microglia cells were
cultured in 96-well plates and treated with different
NOX inhibitors for 1 hour prior to stimulation with
LPS or the protein kinase C activator PMA for a further
24 hours. NO• release and ROS production from micro-
glia were assessed as markers of microglial activation.
Microglia showed significant induction of ROS (F5,16 =
22.81, P <0.001) and NO• (F5,17 = 153.1, P <0.001) upon
LPS and PMA stimulation (Figure 11). Pre-treatment
with the non-specific NADPH oxidase inhibitor, DPI,
reduced NO• and ROS levels in a dose-dependent man-
ner. Pre-treatment with the NOX2 specific inhibitor
peptide, gp91 ds-tat (10 μM), also reduced NO• and
ROS induction.
In order to assess the neurotoxic effects of LPS-
stimulated microglia in oligodendrocytes, co-cultures were
performed with the BV2 microglia cell line. LDH release
was measured in oligodendrocytes 24 hours after co-
culture with BV2 cells in trans-well plates as a marker of
cytotoxicity. Transwell plates containing microglia were
removed prior to assessment of cell death. LPS-stimulated
microglia induced a significant increase in LDH release
from oligodendrocytes 24 hours after co-culture, which
was significantly reduced by pre-treatment of microglia
with DPI prior to LPS administration (F2,6 = 7.2, P <0.05).
Discussion
These data indicate that the expression of the NOX iso-
forms is dependent on cell type and injury status. We now
show that the NOX2 istoype is primarily expressed by
microglia and neurons, NOX3 is primarily expressed by
neurons, and NOX4 is expressed by all three cell types.
Further, NOX2 is the most responsive to injury. Microglia
showed the most altered expression of NOX isoforms after
injury, which is not unexpected, with the most increase in
expression observed at 7 days post-injury, a reported peak
in microglial responses after injury [3,35]. Interestingly,
quantitation of NOX2 protein showed the greatest in-
crease at 24 hours post-injury, with less elevation by 7
Figure 5 Microglia show expression of NOX2, NOX3, and NOX4 in vitro. After stimulation with LPS, the distribution of NOX2 changes to
surround the nucleus. In contrast, NOX3 staining disappears and the intensity of NOX4 staining increases with LPS stimulation. Microglia stained
with NOX2 and NOX4 were stimulated for 24 hours and microglia stained with NOX3 were stimulated for 2 hours. For NOX2, bar = 20 μm. For
NOX3 and NOX4, bar = 50 μm.
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days and 28 days. Because cell type was not taken into ac-
count with the quantitation, this suggests that neurons,
which showed greater NOX2 immunostaining at 24 hours
and none at 7 days, may be the source of much of the
NOX2 acutely after injury, and thus much of the ROS
production observed at acute time points.
NOX expression has previously been reported to in-
crease in several CNS injury models, including brain
[17,27] and spinal cord injury [18,20,36]. In the spinal
cord, NOX expression is up-regulated through 6 months
after injury in rodents [19], and ROS production has been
reported from 6 hours to several months post-injury in
humans [35,36]. In the injured brain, NOX activity has
been shown to have 2 peaks: the first at approximately 1
hour after injury and the second 24 to 96 hours after
injury [17,26-28]. Our results support these studies and
suggest that the acute increases may occur in neurons,
while the more delayed peaks are likely occurring in
microglia/macrophages.
NOX2 was found most prominently in CD11b+ mac-
rophages and microglia, and the degree of double stain-
ing increased after injury, in agreement with previous
studies [17-19]. NOX4 expression was also up-regulated
after injury in these cells. This finding was repeated in
BV2 cell cultures, an immortalized cell line of microglial
cells, which showed similar patterns of NOX2 and 4 ex-
pression after LPS stimulation. As we did not differenti-
ate between overall expression and expression per cell,
it is possible that the observed increase in NOX2/4 is
not necessarily an increase in expression, but an
increase in cell number. Future studies will determine if
the amount of NOX2/4 per cell is increased or if the
overall cell number is the sole reason for this increase.
NOX activity in microglia/macrophages can exacer-
bate the post-injury inflammatory response via activity
on transcription factors that ultimately increase pro-
inflammatory cytokine expression [37,38]. Inhibition of
NOX activation in microglia, via administration of the
non-specific inhibitor apocynin or knockout of the
p47PHOX subunit, not only reduces inflammatory re-
sponses, but also polarizes microglia into the M2 or al-
ternative activation phenotype [39], which may have
significant therapeutic implications. NOX inhibition has
also been shown to reduce chemotaxis of neutrophils
[40]. Our data support these findings and indicate that
inhibition of NOX activity, either generally via the non-
Figure 6 Neurons expressed NOX2 in the brain ipsilateral to the injury site. Cells positive for NeuN were also positive for NOX2 in naïve
tissue and at 24 hours and 28 days post-injury, but not at 7 days post-injury. Arrows indicate double-labeled cells. Bar = 20 μm (naïve, 24 hours);
50 μm (7 days, 28 days).
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Figure 7 Neurons were positive for NOX4 in the brain ipsilateral to the injury site. NeuN+ (green) cells were also immunolabeled with
NOX4 (red) in sham-injured brains, at 24 hours and at 28 days post-injury, but not in 7 days post-injury brains. Arrows indicate double-labeled
cells. Bar = 50 μm (sham and 7 days); 20 μm (24 hours).
Figure 8 PC12 neuronal-like cells NOX2, NOX3, and NOX4 in vitro. PC12 cells were cultured in conditioned media from control or
LPS-stimulated microglia for 2 hours (NOX2) or 24 hours (NOX4). After addition of LPS-stimulated microglial media, the intensity of NOX2 staining
remained the same, but the intensity NOX4 decreased in the neurons. Bar = 20 μm (NOX2); 50 μm (NOX4).
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specific inhibitor DPI, or specifically of NOX2 using
gp91-ds-tat, can reduce aspects known to contribute to
inflammation, including NO• and ROS production.
NOX activity is also intimately associated with cellular
toxicity (for a review, see [41]). Activated macrophages/
microglia release an array of inflammatory cytokines,
which induce the release of glutamate, enhancing stimula-
tion on N-methyl-D-aspartate (NMDA) receptors [42]. In
addition to the release of free radicals, this cytokine release
may result in neuronal and oligodendrocyte toxicity and
death. In vitro inhibition of NOX activity reduces micro-
glial induction of neuronal [18] and oligodendrocyte cell
death [43], which is supported by our study. Co-culture of
microglia with oligodendrocytes, which are sensitive to
ROS and ROS metabolites produced by microglia [44],
demonstrated that non-specific inhibition of NOX re-
sulted in significantly reduced oligodendrocyte cell death.
This suggests that NOX activity contributes to the toxicity
Figure 9 Astrocytes were positive for NOX4 in the brain ipsilateral to the injury site. GFAP+ (green) cells were not immunolabeled with
NOX4 (red) in sham-injured brains or at 7 days post-injury, but were observed at 24 hours and 28 days post-injury (red). Arrows indicate double-
labeled cells, which appear as yellow (far right panels). Bar = 50 μm (sham and 7 days); 20 μm (24 hours, 28 days).
Figure 10 Astrocytes were positive for NOX2 (A) and NOX4 (B) in vitro. Astrocytes were cultured for 24 hours with or without LPS
stimulation. Astrocyte expression of NOX2 and NOX4 did not change with LPS stimulation (A, B). Bar = 50 μm.
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of M1-activated microglia during a neuroinflammatory
challenge and its inhibition may have beneficial conse-
quences after TBI. Inhibition of NOX activity, through
non-specific approaches using apocynin or specific inhibi-
tors of NOX2, has been shown to reduce neuronal death
after spinal cord injury [45], TBI [26,27], and cortical is-
chemia [46,47]. In addition, knockout of NOX2 reduces
neuronal death after TBI [17]. New research is currently
investigating the effects of specific NOX isotype inhibition,
with pharmacological or small molecule inhibitors that
target NOX2 versus other isotypes [12,48,49]. Qualifying
the temporal and cellular localization of NOX2 and other
isotypes is an important step in furthering studies that
target NOX isotype inhibition.
In addition to microglia and macrophages, neurons
and astrocytes were found to express NOX isotypes. In
fact, neurons were the only cell type to express all NOX
isotypes investigated. Interestingly, NOX2 and NOX4
were only expressed by neurons in sham tissue or acutely
after injury, while NOX3 was expressed in neurons consti-
tutively in brain regardless of injury state. Previous studies
have shown that after a glutamate injection into the
cortex, NOX2 was only observed in neurons at 6 hours
and had begun to diminish by 24 hours [50]. NOX2 and
NOX4 were also expressed by neurons in vitro. On the
other hand, astrocytic NOX expression in vivo was re-
stricted to the NOX4 isotype. While NOX2 was observed
in astrocytes in vitro, it is unclear why NOX2 was not
observed in these cells in vivo, as previous studies have
shown that brain astrocytes in vivo express NOX2 [51]
and may reflect a technical difficulty.
Currently, the function of NOX isotypes in these cell
types is not fully understood. For example, neuronal
NOX2 has been shown to contribute to both intra- and
extracellular release of ROS following NMDA stimulation
[10,52] and NOX4 has been observed in spinal cord neu-
rons to play a significant role in post-injury neuropathic
pain [53], but the role of NOX3 is unclear. Functionally,
NOX2 has been shown to play a role in potentiating
inflammation and enhancing the release of matrix
metalloproteinases by brain astrocytes [54], while the
function of NOX4 in these cells is unclear [55]. Future
work will investigate the functional importance of
NOX isoform neuronal and astrocyte expression.
Figure 11 NOX inhibition reduces microglial activation and toxicity. BV2 microglial cells incubated with PMA or LPS showed an increase in
ROS production (A). Pre-incubation with the NOX2 specific inhibitor gp91ds-tat (10 μM), or the NOX non-specific inhibitor DPI (10 μM),
significantly reduced the ROS production induced by PMA and LPS, respectively (A). LPS also induced NO• release from BV2 cells, which was
inhibited by gp91-ds-tat (10 μM) and in a dose-dependent fashion by DPI (B). Co-culture of oligodendrocytes with LPS-stimulated BV2 cells for 24
hours resulted in a significant increase in oligodendrocyte cell death, as measured by LDH release (C). Pre-treatment of BV2 cells with DPI (10 μM)
for 1 hour prior to LPS administration blocked this toxic effect. Bars represent mean ± SD. *P <0.05; **P <0.01; ***P <0.001.
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Conclusions
In summary, we now show that NOX isotypes have a
temporal and cellular dependence that has not been
previously observed, which may suggest different mecha-
nisms of activation of the isotypes in each cell. These data
provide support for the observations of ROS-mediated
cellular damage and oxidative stress after injury, and may
provide insight into the design of future therapeutic ap-
proaches for oxidative damage to the injured brain.
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